Tamper-resistant drugs cannot solve the opioid crisis.
Health care organizations have implemented various strategies to address the opioid epidemic. This commentary explains why use of tamper-resistant drug formulations to avert opioid-related harm is unlikely to work and may hinder policy-focused solutions to improve opioid prescribing and use.